Vildagliptin, Sitagliptin Have Similar Effects on Incretin

This article originally appeared here.
Share this content:
Vildagliptin, Sitagliptin Have Similar Effects on Incretin
Vildagliptin, Sitagliptin Have Similar Effects on Incretin

MONDAY, June 20, 2016 (HealthDay News) -- The dipeptidyl peptidase-4 (DPP-4) inhibitors vildagliptin and sitagliptin have similar effects on incretin hormone secretion, according to a study published online June 14 in Diabetes, Obesity and Metabolism.

Oleg Baranov, from the Diabeteszentrum Bad Lauterberg in Germany, and colleagues compared the clinical effects of vildagliptin and sitagliptin in 24 patients with type 2 diabetes (12 diet/exercise, 12 on metformin). Participants were treated in randomized order for seven to nine days with vildagliptin, sitagliptin, or placebo.

The researchers found that with vildagliptin and sitagliptin, intact glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide concentrations were doubled. In most patients, meal-related total GLP-1 responses were reduced by vildagliptin and sitagliptin treatment (P = 0.0005 and 0.019, respectively), with considerable inter-individual variation. In those with greater increases in intact GLP-1 relative to total GLP-1 and who had greater reductions in fasting plasma glucose after DPP-4 inhibition, L-cell feedback was more pronounced. Overall, K-cell feedback inhibition was not significant. No between-group differences were seen in any clinical parameters.

"Vildagliptin and sitagliptin affected incretin hormones, glucose concentrations, insulin, and glucagon secretion in a similar manner," the authors write. "Inter-individual variations in L-cell feedback inhibition may indicate heterogeneity in the clinical response to DPP-4 inhibition."

Several authors disclosed financial ties to pharmaceutical companies, including Novartis Pharma, which manufactures vildagliptin and funded the study.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Pace of Influenza Activity Picking Up Across the United States

Pace of Influenza Activity Picking Up Across the ...

Dominant strain right now is H3N2, CDC epidemiologist notes

Artificial Sweetener Use Up in U.S. Children in Recent Years

Artificial Sweetener Use Up in U.S. Children in ...

Consumption of low-calorie sweeteners rose from 8.7 to 25.1 percent from 1999 to 2012

Fecal Transplant No Better Than Oral Antibiotic for C. difficile

Fecal Transplant No Better Than Oral Antibiotic for ...

In direct comparison, researchers found no real difference between transplant, antibiotic treatment

is free, fast, and customized just for you!

Already a member?

Sign In Now »